BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He YC, Chen JW, Cao J, Pan DY, Qiao JG. Toxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing rats. World J Gastroenterol 2003; 9(8): 1795-1798 [PMID: 12918123 DOI: 10.3748/wjg.v9.i8.1795] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Dong Y, Chin SF, Blanco E, Bey EA, Kabbani W, Xie XJ, Bornmann WG, Boothman DA, Gao J. Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy. Clin Cancer Res 2009;15:131-9. [PMID: 19118040 DOI: 10.1158/1078-0432.CCR-08-1691] [Cited by in Crossref: 51] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
2 Kalantarian P, Najafabadi AR, Haririan I, Vatanara A, Yamini Y, Darabi M, Gilani K. Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery. Int J Nanomedicine 2010;5:763-70. [PMID: 21042422 DOI: 10.2147/IJN.S12415] [Cited by in Crossref: 38] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
3 Abdul Mahdi S, Ali Kadhim A, Albukhaty S, Nikzad S, Haider AJ, Ibraheem S, Ali Kadhim H, Al-musawi S. Gene expression and apoptosis response in hepatocellular carcinoma cells induced by biocompatible polymer/magnetic nanoparticles containing 5-fluorouracil. Electronic Journal of Biotechnology 2021;52:21-9. [DOI: 10.1016/j.ejbt.2021.04.001] [Reference Citation Analysis]
4 Haggag YA, Osman MA, El-gizawy SA, Goda AE, Shamloula MM, Faheem AM, Mccarron PA. Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice. Biomedicine & Pharmacotherapy 2018;105:215-24. [DOI: 10.1016/j.biopha.2018.05.124] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
5 Tseng C, Chen J, Wu Y, Fang H, Lin F, Tang T. Development of lattice-inserted 5-Fluorouracil-hydroxyapatite nanoparticles as a chemotherapeutic delivery system. J Biomater Appl 2015;30:388-97. [DOI: 10.1177/0885328215588307] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
6 Gui R, Wan A, Jin H. Retracted Article: Facile synthesis of quantum dots/mesoporous silica/quantum dots core/shell/shell hybrid microspheres for ratiometric fluorescence detection of 5-fluorouracil in human serum. Analyst 2013;138:5956-64. [DOI: 10.1039/c3an01089a] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
7 Badran MM, Mady MM, Ghannam MM, Shakeel F. Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer. International Journal of Biological Macromolecules 2017;95:643-9. [DOI: 10.1016/j.ijbiomac.2016.11.098] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
8 Lopes S, Simeonova M, Gameiro P, Rangel M, Ivanova G. Interaction of 5-fluorouracil loaded nanoparticles with 1,2-dimyristoyl-sn-glycero-3-phosphocholine liposomes used as a cellular membrane model. J Phys Chem B 2012;116:667-75. [PMID: 22148190 DOI: 10.1021/jp210088n] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
9 Nair K L, Jagadeeshan S, Nair SA, Kumar GS. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Int J Nanomedicine 2011;6:1685-97. [PMID: 21980233 DOI: 10.2147/IJN.S20165] [Cited by in Crossref: 11] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
10 Garg A, Garg S, Sahu NK, Rani S, Gupta U, Yadav AK. Heparin appended ADH-anionic polysaccharide nanoparticles for site-specific delivery of usnic acid. International Journal of Pharmaceutics 2019;557:238-53. [DOI: 10.1016/j.ijpharm.2018.12.049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
11 Wadee A, Pillay V, Choonara YE, du Toit LC, Penny C, Ndesendo VM, Kumar P, Murphy CS. Recent advances in the design of drug-loaded polymeric implants for the treatment of solid tumors. Expert Opinion on Drug Delivery 2011;8:1323-40. [DOI: 10.1517/17425247.2011.602671] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
12 Jin H, Liu X, Gui R, Wang Z. Facile synthesis of gold nanorods/hydrogels core/shell nanospheres for pH and near-infrared-light induced release of 5-fluorouracil and chemo-photothermal therapy. Colloids Surf B Biointerfaces 2015;128:498-505. [PMID: 25794443 DOI: 10.1016/j.colsurfb.2015.02.049] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
13 Ashour AE, Badran M, Kumar A, Hussain T, Alsarra IA, Yassin AEB. Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles. Int J Nanomedicine 2019;14:9259-73. [PMID: 31819428 DOI: 10.2147/IJN.S223368] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
14 Yadav AK, Agarwal A, Rai G, Mishra P, Jain S, Mishra AK, Agrawal H, Agrawal GP. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Drug Deliv 2010;17:561-72. [PMID: 20738221 DOI: 10.3109/10717544.2010.500635] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
15 Abdel-latif RT, Wadie W, Abdel-mottaleb Y, Abdallah DM, El-maraghy NN, El-abhar HS. Reposition of the anti-inflammatory drug diacerein in an in-vivo colorectal cancer model. Saudi Pharmaceutical Journal 2021. [DOI: 10.1016/j.jsps.2021.12.009] [Reference Citation Analysis]
16 Abdel-hameed S, El-kady A, Marzouk M. Magnetic glass ceramics for sustained 5-fluorouracil delivery: Characterization and evaluation of drug release kinetics. Materials Science and Engineering: C 2014;44:293-309. [DOI: 10.1016/j.msec.2014.08.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
17 R Ebrahim A, El-Mesery M, El-Karef A, Eissa LA. Vitamin D potentiates anti-tumor activity of 5-fluorouracil via modulating caspase-3 and TGF-β1 expression in hepatocellular carcinoma-induced in rats. Can J Physiol Pharmacol 2018;96:1218-25. [PMID: 30205014 DOI: 10.1139/cjpp-2018-0445] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
18 Nasr M, Ghorab MK, Abdelazem A. In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting. Acta Pharm Sin B 2015;5:79-88. [PMID: 26579429 DOI: 10.1016/j.apsb.2014.12.001] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 9.8] [Reference Citation Analysis]
19 Sun M, Wang M, Chen M, Dagnaes-Hansen F, Le DQ, Baatrup A, Horsman MR, Kjems J, Bünger CE. A tissue-engineered therapeutic device inhibits tumor growth in vitro and in vivo. Acta Biomater 2015;18:21-9. [PMID: 25686557 DOI: 10.1016/j.actbio.2015.02.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
20 Abd-Rabou AA, Bharali DJ, Mousa SA. Taribavirin and 5-Fluorouracil-Loaded Pegylated-Lipid Nanoparticle Synthesis, p38 Docking, and Antiproliferative Effects on MCF-7 Breast Cancer. Pharm Res 2018;35:76. [PMID: 29488022 DOI: 10.1007/s11095-017-2283-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
21 Saddik MS, Elsayed MMA, Abdelkader MSA, El-Mokhtar MA, Abdel-Aleem JA, Abu-Dief AM, Al-Hakkani MF, Farghaly HS, Abou-Taleb HA. Novel Green Biosynthesis of 5-Fluorouracil Chromium Nanoparticles Using Harpullia pendula Extract for Treatment of Colorectal Cancer. Pharmaceutics 2021;13:226. [PMID: 33562032 DOI: 10.3390/pharmaceutics13020226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
22 El-Ghannam A, Ricci K, Malkawi A, Jahed K, Vedantham K, Wyan H, Allen LD, Dréau D. A ceramic-based anticancer drug delivery system to treat breast cancer. J Mater Sci Mater Med 2010;21:2701-10. [PMID: 20644983 DOI: 10.1007/s10856-010-4121-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]